Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 24UNKNOWN 1OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Esophageal Neoplasms 7Breast Neoplasms 6Rectal Neoplasms 4Neoplasms 4Radiation Injuries 2Lymphoma, Large B-Cell, Diffuse 2Lung Neoplasms 2Hormone Receptor Positive Advanced Breast Cancer 2Brain Neoplasms 2Varicose Veins 1Syphilis 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Recurrence 1Pathologic Complete Response 1Papillomavirus Infections 1Mesothelioma, Malignant 1Lymphoid Neoplasm 1Lymphocele 1Hyperparathyroidism, Primary 1Hypercalcemia 1Head and Neck Neoplasms 1HIV Infections 1HER2-positive Breast Cancer 1Cardiovascular Diseases 1Carcinoma, Ovarian Epithelial 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Hepatocellular 1

Interventions

Neoadjuvant Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
UNKNOWN × Observational × Pathologic Complete Response × Clear all
NCT05441098 2022-07-01

Construction and Validation of an Assessment Model of PCR After NAT on Breast Cancer Patients With AI Technology

ChineseAMS

Unknown
1,821 enrolled
Breast

Pathologic Complete Response, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡